Cargando…
Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection
Effective therapies are urgently needed for the SARS-CoV-2/COVID-19 pandemic. We identified panels of fully human monoclonal antibodies (mAbs) from large phage-displayed Fab, scFv, and VH libraries by panning against the receptor binding domain (RBD) of the SARS-CoV-2 spike (S) glycoprotein. A high-...
Autores principales: | Li, Wei, Chen, Chuan, Drelich, Aleksandra, Martinez, David R., Gralinski, Lisa E., Sun, Zehua, Schäfer, Alexandra, Kulkarni, Swarali S., Liu, Xianglei, Leist, Sarah R., Zhelev, Doncho V., Zhang, Liyong, Kim, Ye-Jin, Peterson, Eric C., Conard, Alex, Mellors, John W., Tseng, Chien-Te K., Falzarano, Darryl, Baric, Ralph S., Dimitrov, Dimiter S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703590/ https://www.ncbi.nlm.nih.gov/pubmed/33139569 http://dx.doi.org/10.1073/pnas.2010197117 |
Ejemplares similares
-
High Potency of a Bivalent Human V(H) Domain in SARS-CoV-2 Animal Models
por: Li, Wei, et al.
Publicado: (2020) -
Effective killing of cells expressing CD276 (B7-H3) by a bispecific T cell engager based on a new fully human antibody
por: Liu, Xianglei, et al.
Publicado: (2021) -
Potent neutralization of SARS-CoV-2 by human antibody heavy-chain variable domains isolated from a large library with a new stable scaffold
por: Sun, Zehua, et al.
Publicado: (2020) -
Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice
por: Liu, Xianglei, et al.
Publicado: (2020) -
Chimeric antigen receptor-T cells are effective against CEACAM5 expressing non-small cell lung cancer cells resistant to antibody-drug conjugates
por: Kim, Ye-Jin, et al.
Publicado: (2023)